IA-14069

DRUG2 trials

Sponsors

ILAb Co., Ltd.

Conditions

HealthyRheumatoid Arthritis

Phase 1

SAD Study of IA-14069

CompletedNCT05317741

ILAb Co., Ltd.Healthy

Start: 2021-08-23End: 2022-09-08Updated: 2023-01-04

MAD Study of IA-14069

CompletedNCT05533372

ILAb Co., Ltd.Healthy, Rheumatoid Arthritis

Start: 2022-10-10End: 2025-10-15Updated: 2026-08-19